Data as of Sep 19
| -0.006 / -2.58%|
The 3 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 0.75. The median estimate represents a +340.53% increase from the last price of 0.23.
The current consensus among 3 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.